Hydrochloric Acid

Hydrochloric Acid

SCHEMBL913640

Cl.O[Si](O)(O)O.[AlH3].[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3368586 0.94
Hydrochloric Acid SCHEMBL28241380 0.94
SCHEMBL10354486 0.93
Hydrochloric Acid SCHEMBL5864569 0.93
Hydrochloric Acid SCHEMBL1021787 0.93
SCHEMBL645392 0.86
SCHEMBL2472593 0.86
SCHEMBL524428 0.86
SCHEMBL41807 0.86
Hydrogen Sulfide SCHEMBL21352579 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008145361-A1 MINERAL-FIBER SOLID DISPERSION, METHOD FOR PREPARING THE SAME, AND USE THEREOF AS PHARMACEUTICAL TABLETING AID THE JORDANIAN PHARMACEUTICAL MANUFACTURING CO. (JO) 2008-12-04 WO claimed
EP-1997480-A1 Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid The Jordanian Pharmaceutical Manufacturing Co. (JO) 2008-12-03 EP claimed
US-8404714-B2 Combinations to improve animal health and performance NOVUS INTERNATIONAL, INC. (US) 2013-03-26 US disclosed
US-20110172269-A1 ANTIOXIDANT COMBINATIONS FOR USE IN FEED RATIONS TO INCREASE MILK PRODUCTION AND MILK FAT NOVUS INTERNATIONAL INC. (US) 2011-07-14 US disclosed
US-7910604-B2 Antioxidant combinations for use in feed rations to increase milk production and milk fat NOVUS INTERNATIONAL, INC. (US) 2011-03-22 US disclosed
US-20110021461-A1 COMBINATIONS TO IMPROVE ANIMAL HEALTH AND PERFORMANCE NOVUS INTERNATIONAL INC. (US) 2011-01-27 US disclosed
WO-2010144972-A1 A CATALYTIC MATERIAL, METHOD OF MANUFACTURE AND METHOD OF USE NEWSQUARE TRADING LIMITED (CN) 2010-12-23 WO disclosed
WO-2009088879-A1 COMBINATIONS TO IMPROVE ANIMAL HEALTH AND PERFORMANCE NOVUS INTERNATIONAL INC. (US) 2009-07-16 WO disclosed
EP-2037923-A2 ANTIOXIDANT COMBINATIONS FOR USE IN RUMINANT FEED RATIONS HAVING A FAT SOURCE Novus International, Inc. (US) 2009-03-25 EP disclosed
WO-2008145361-A1 MINERAL-FIBER SOLID DISPERSION, METHOD FOR PREPARING THE SAME, AND USE THEREOF AS PHARMACEUTICAL TABLETING AID THE JORDANIAN PHARMACEUTICAL MANUFACTURING CO. (JO) 2008-12-04 WO disclosed
EP-1997480-A1 Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid The Jordanian Pharmaceutical Manufacturing Co. (JO) 2008-12-03 EP disclosed
US-20080014323-A1 ANTIOXIDANT COMBINATIONS FOR USE IN FEED RATIONS TO IMPROVE ANTIOXIDANT STATUS OF RUMINANTS NOVUS INTERNATIONAL INC. (US) 2008-01-17 US disclosed
US-20080015217-A1 ANTIOXIDANT COMBINATIONS FOR USE IN RUMINANT FEED RATIONS NOVUS INTERNATIONAL, INC. (US) 2008-01-17 US disclosed
US-20080015218-A1 ANTIOXIDANT COMBINATIONS FOR USE IN RUMINANT FEED RATIONS HAVING A FAT SOURCE NOVUS INTERNATIONAL INC. (US) 2008-01-17 US disclosed
US-20080014301-A1 ANTIOXIDANT COMBINATIONS FOR USE IN FEED RATIONS TO INCREASE MILK PRODUCTION AND MILK FAT NOVUS INTERNATIONAL INC. (US) 2008-01-17 US disclosed
WO-2008008637-A2 ANTIOXIDANT COMBINATIONS FOR USE IN RUMINANT FEED RATIONS HAVING A FAT SOURCE NOVUS INTERNATIONAL INC. (US) 2008-01-17 WO disclosed
WO-2006017546-A1 ANIONIC-CONTAING FEED SUPPLEMENTS HAVING A LOW PROTEIN BY-PASS VALUE NOVUS INTERNATIONAL, INC. (US) 2006-02-16 WO disclosed
US-20060029646-A1 Anionic-containing feed supplements having a low protein by-pass value NOVUS INTERNATIONAL, INC. 2006-02-09 US disclosed